Zhang Le, Guan Yunpeng, Cheng YuenYee, Cokcetin Nural N, Bottomley Amy L, Robinson Andrew, Harry Elizabeth J, van Oijen Antoine M, Su Qian Peter, Jin Dayong
Institute for Biomedical Materials and Devices (IBMD), University of Technology Sydney, Ultimo, Australia.
Australian Institute for Microbiology & Infection (AIMI), University of Technology Sydney, Ultimo, Australia.
Elife. 2025 Jul 9;13:RP95058. doi: 10.7554/eLife.95058.
The killing mechanism of many antibiotics involves the induction of DNA damage, either directly or indirectly, which activates the SOS response. RecA, the master regulator of the SOS response, has been shown to play a central role in the evolution of resistance to fluoroquinolones, even after short-term exposure. While this paradigm is well established for DNA-damaging antibiotics, it remains unclear whether β-lactams elicit similar resistance dynamics or depend on RecA and SOS-mediated mechanisms. In this study, we observed a rapid and stable evolution of β-lactam resistance (20-fold MIC increase within 8 hr) in lacking RecA after a single exposure to ampicillin. Contrary to expectation, this resistance emerged through an SOS-independent mechanism involving two distinct evolutionary forces: increased mutational supply and antibiotic-driven selection. Specifically, we found that RecA deletion impaired DNA repair and downregulated base excision repair pathways, while concurrently repressing the transcription of antioxidative defence genes. This dual impairment led to excessive accumulation of reactive oxygen species (ROS), which in turn promoted the emergence of resistance-conferring mutations. While ampicillin treatment did not alter survival, it selectively enriched for rare mutants arising in the RecA-deficient and ROS-elevated background. Collectively, our findings demonstrate that this oxidative environment, together with compromised DNA repair capacity, increases genetic instability and creates a selective landscape favouring the expansion of resistant clones. These results highlight the repair-redox axis as a key determinant of bacterial evolvability under antimicrobial stress.
许多抗生素的杀菌机制涉及直接或间接诱导DNA损伤,从而激活SOS反应。RecA是SOS反应的主要调节因子,已被证明在对氟喹诺酮类药物的耐药性进化中起着核心作用,即使在短期接触后也是如此。虽然这种模式在DNA损伤抗生素方面已得到充分确立,但β-内酰胺类抗生素是否引发类似的耐药动态或是否依赖RecA和SOS介导的机制仍不清楚。在本研究中,我们观察到在单次暴露于氨苄青霉素后,缺乏RecA的菌株中β-内酰胺耐药性迅速且稳定地进化(8小时内MIC增加20倍)。与预期相反,这种耐药性通过一种不依赖SOS的机制出现,该机制涉及两种不同的进化力量:增加的突变供应和抗生素驱动的选择。具体而言,我们发现RecA缺失会损害DNA修复并下调碱基切除修复途径,同时抑制抗氧化防御基因的转录。这种双重损害导致活性氧(ROS)过度积累,进而促进赋予耐药性的突变出现。虽然氨苄青霉素处理不会改变存活率,但它会选择性地富集在RecA缺陷和ROS升高背景下产生的罕见突变体。总体而言,我们的研究结果表明,这种氧化环境与受损的DNA修复能力一起,增加了遗传不稳定性,并创造了有利于耐药克隆扩增的选择环境。这些结果突出了修复-氧化还原轴作为抗菌应激下细菌进化能力的关键决定因素。